Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > December 15, 2004 - Volume 37 - Issue 5 > Protease Inhibitor and Nonnucleoside Reverse Transcriptase I...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
15 December 2004 - Volume 37 - Issue 5 - pp 1577-1580
Brief Report: Clinical Science

Protease Inhibitor and Nonnucleoside Reverse Transcriptase Inhibitor Concentrations in the Genital Tract of HIV-1-Infected Women

Min, Sherene S. MD; Corbett, Amanda H. PharmD; Rezk, Naser MS; Cu-Uvin, Susan MD; Fiscus, Susan A. PhD; Petch, Leslie PhD; Cohen, Myron S. MD; Kashuba, Angela D. M. PharmD

Collapse Box

Abstract

The pharmacokinetics of antiretrovirals (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and post-exposure prophylaxis regimens. This study is the first to compare ARV concentrations in direct aspirates of cervicovaginal fluid (CVF) and blood plasma (BP). This unique method provides direct assessment of concentrations without the confounding of cervicovaginal lavage dilution. Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary.

© 2004 Lippincott Williams & Wilkins, Inc.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.